CME-CPD

Educational objectives

After participating in this educational activity, participants should be able to:

  • Review current basic science, clinical, and translational research in regional anesthesia and pain medicine with regard to its applicability and their role in the development of novel analgesics and new therapeutic targets.
  • Describe current methods of regional anesthetic/analgesic techniques for perioperative and acute pain management and interventional techniques for neuromodulation and chronic pain management.
  • Perform a risk/benefit analysis of specific regional anesthetic techniques and interventional pain procedures to select optimal choices for surgical anesthesia, perioperative pain control and chronic pain management.
  • Evaluate and debate new trends, techniques, and controversies in therapeutic and diagnostic modalities in regional anesthesia and pain management.
  • Describe the role of pain management and other anesthesia strategies to support Enhanced Recovery After Surgery (ERAS) pathways.
  • Address common clinical challenges in the practice of regional anesthesia, acute and chronic pain management, including those encountered in special populations.
  • Establish safe and appropriate opioid prescription guidelines in the current epidemic environment of opioid abuse for acute and chronic pain management.
  • Incorporate modern opioid and non-opioid systemic analgesic agents and multimodal analgesic protocols into perioperative pain medicine and chronic pain management.
  • Identify the barriers to implementation of current regional anesthetic/analgesic techniques and interventional pain procedures into practice, and discuss strategies to overcome those barriers.
  • Describe emerging pharmacologic products and technologies of potential future use in regional anesthesia and pain medicine and identify pros and cons of their actions.
  • Describe both short- and long-term outcome variables that are improved by effective regional anesthesia and pain medicine.
  • Discuss medico-legal issues related to regional anesthesia and pain medicine.
  • Assemble a valuable network of national and international anesthesia and pain colleagues, patient, lawyer and surgical colleagues for consultation and future self-directed learning.

Target audience

The ASRA CME program provides educational activities to physicians, residents, fellows, and scientists.  ASRA supports a multi-disciplinary and inter-professional approach to continuing education and patient care by also providing relevant education for other healthcare professionals not directly engaging in interventional regional anesthesia and/or pain medicine procedures. ASRA offers learning opportunities to the national and international healthcare community.

Accreditation and credit designation statements

Credits by Day

Maximum

Wednesday (pre-meeting)

8

Thursday

8.5

Friday

7.5

Saturday

7.25

Total Credits:

31.25

Physicians: The American Society of Regional Anesthesia and Pain Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

The American Society of Regional Anesthesia and Pain Medicine designates this live activity for a maximum of 31.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PAs (Physicians Assistants): AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 31.25 hours of Category 1 credit for completing this program.

Nurse Practitioners: The American Association of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME. This activity has been approved for a maximum of 31.25 AMA PRA Category 1 Credits™.

The American Board of Anesthesiology® MOCA®

Part II Patient Safety CME: This patient safety activity helps fulfil the patient safety CME requirement for Part II of the Maintenance of Certification in Anesthesiology Program (MOCA) of The American Board of Anesthesiology (ABA). Please consult the ABA website, http://www.theaba.org/MOCA/MOCA-2-0-Part-2, for a list of all MOCA requirements. Max. credits 13.25.

Thursday (max. 4.25 credits)

  • PS-01a RA-Acute Pain Parallel Session, Block Success: Needle and Injection Endpoints (1.75 credits)
  • PS-01d RA-Acute Pain Parallel Session, Pediatric Regional Anesthesia and Pain Management SIG Panel (1.75 credits)
  • PS-02a RA-Acute Pain Parallel Session, Block Safety: Neurologic Complications (1.5 credits)
  • PS-02d RA-Acute Pain Parallel Session, Perioperative Point-of-Care Ultrasound SIG Panel (1.5 credits)
  • PBLD-04, Nerve Injury After Regional Anesthesia: Best Practices and Medical and Legal Perspectives (1 credit)
  • PBLD-06, Persistent Headache After One Epidural Blood Patch: What to do Next? (1 credit)
  • PBLD-08, Don't Block that Patient: He May Develop a Compartment Syndrome! (1 credit)

Friday (max. 4.5 credits)

  • PS-06e Chronic Pain Parallel Session, Intrathecal Therapy Panel (1.5 credits)
  • PS-07b Chronic Pain Parallel Session, The Opioid Epidemic: Global Perspective on the Appropriate Use of Chronic Opioids (1.5 credits)
  • PS-08a RA-Acute Pain Parallel Session, Pharmacology Update: Hemostasis Altering Drugs and Regional Anesthesia Safety (1.5 credits)

Saturday (max. 4.5 credits)

  • PS-09d RA/Acute Pain Parallel Session, Obstetrics Forum (1.5 credits)
  • PS-11a RA/Acute Pain Parallel Session, Complications After Regional Anesthesia and Surgery (1.5 credits)
  • PS-11b Chronic Pain Parallel Session, Complications of Chronic Pain Management and Medico-Legal Cases (1.5 credits)
  • PS-12a RA/Acute Pain Parallel Session, Regional Anesthesia Related Complications and Medico-Legal Issues (1.5 credits)
  • PS-12d Chronic Pain Parallel Session, Marijuana and Cannabinoids in Chronic Pain Management (1.5 credits)

Part IV High-Fidelity Simulation CME:  This activity contributes to the Part IV Improvement in Medical Practice requirement of the American Board of Anesthesiology’s (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0™. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 Part IV requirements and their associated point values. Max. 3.75 credits.

  • WS-18 Simulation Workshop, Crisis Management for the Regional Anesthesiologist (3.75 credits)
  • WS-20 High-Fidelity Simulator for Thoracic Blocks (2.0 credits)
  • WS-26 High-Fidelity Simulator for Thoracic Blocks (2.0 credits)
  • WS-28 Simulation Workshop, Crisis Management for the Regional Anesthesiologist (3.75 credits)

Credit Reporting to the ABA: ASRA is an ABA-approved provider and, as a service to ASRA members and participants, CME credits are reported to the ABA. Participants must include their correctly formatted ABA ID number (34567890) during the online evaluation and credit claim process available at the conclusion of the activity. Once the online evaluation and credit claim process is closed, certificates will be issued and credits reported to the ABA. After this time, participants may request their CME certificate by contacting asrameetings@asra.com, but ASRA will no longer report credits to the ABA, which will then be the individual participant’s responsibility.

ASRA-ASA Ultrasound-Guided Regional Anesthesia (UGRA) Education and Clinical Training Portfolio

The Ultrasound-Guided Regional Anesthesia Education and Clinical Training Portfolio is a joint ASRA - ASA initiative designed for anesthesiologists who wish to distinguish themselves in the field and provide evidence of training and experience.  The portfolio guides participants through a comprehensive educational and training experience that fulfills current recommendations for ultrasound-guided regional anesthesia (UGRA). This ASRA course has been approved for knowledge base and technical skills components of the portfolio. For more information and approved sessions, visit the ASA website.

International credits

Royal College of Physicians and Surgeons of Canada: The Royal College of Physicians and Surgeons of Canada has agreements based on the mutual recognition of credit points with the American Medical Association for live educational events.  You may submit your CME certificate directly for credit recognition of this accredited group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada. For more information, visit: www.royalcollege.ca 

European Accreditation Council for Continuing Medical Education (UEMS-EACCME): The UEMS-EACCME has agreements based on the mutual recognition of credit points with the American Medical Association for live educational events.  Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS): www.uems.net 

Commercial support disclosure

This course is supported, in part, by educational grants and in-kind support from industry. All support is managed in strict accordance with the ACCME’s Standards for Commercial Support. Appropriate acknowledgement of all supporting organizations is made to participants prior to the educational activity in the program guide, on the event website, and with signage during the meeting.  View the guidelines for company representative and in-kind support.

Disclosure and resolution of personal conflicts of interest

In accordance with the ACCME’s Standards for Commercial Support and related policies, ASRA is committed to ensuring balance, independence, objectivity, and scientific rigor in its CME/CPD activities. Those in control of the educational content disclose all relevant relationships (financial or other) with any commercial interest that they or their spouse/partner have had within the past 12 months. If an individual refuses to disclose, they are disqualified from participating. Disclosure information is evaluated and conflicts of interest resolved. Disclosure is made to participants prior to the activity. Participants are asked to evaluate the objectivity and independence. Off-label or investigational use of a therapeutic product is also disclosed.